Skip to main content
Livermore
Livermore
ZHEN

Elicio Therapeutics, Inc.

ELTX
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001601485

No open-market purchases or sales by Elicio Therapeutics, Inc. insiders were filed in the last 90 days; 48 institutions reported holding it in 13F filings for Q2 2026, worth $15.3M in total; no superinvestor holds it.

13F holders, Q1 2026

Institutional positions in Elicio Therapeutics, Inc. as of Mar 31, 2026. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works

Institutional holders
47
+12 vs. Q4 2025
Shares held
2.64M
+1.06M (+67.5%) vs. Q4 2025
Total value
$28.2M
+$15.7M (+125.0%) vs. Q4 2025
New holders
19
13 more added
Sold out
7
6 more reduced

2 institutions that held it in Q4 2025 haven't filed for Q1 2026 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.

Compare with Q4 2025: new holders, sold out and not filed yet

Holders and value by quarter

Institutions reporting ELTX on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.

Institutional holdersQ1 2026: 47 institutions
Q1 2021: 41 institutionsQ2 2021: 41 institutionsQ3 2021: 47 institutionsQ4 2021: 53 institutionsQ1 2022: 47 institutionsQ2 2022: 43 institutionsQ3 2022: 38 institutionsQ4 2022: 30 institutionsQ1 2023: 28 institutionsQ2 2023: 15 institutionsQ3 2023: 18 institutionsQ4 2023: 18 institutionsQ1 2024: 18 institutionsQ2 2024: 20 institutionsQ3 2024: 18 institutionsQ4 2024: 17 institutionsQ1 2025: 24 institutionsQ2 2025: 21 institutionsQ3 2025: 28 institutionsQ4 2025: 37 institutionsQ1 2026: 47 institutionsQ2 2026: 48 institutions
Value heldQ1 2026: $28.2M
Q1 2021: $92.0MQ2 2021: $66.5MQ3 2021: $69.3MQ4 2021: $20.3MQ1 2022: $13.8MQ2 2022: $5.90MQ3 2022: $4.71MQ4 2022: $3.98MQ1 2023: $2.56MQ2 2023: $2.71MQ3 2023: $2.80MQ4 2023: $2.78MQ1 2024: $3.08MQ2 2024: $2.68MQ3 2024: $2.48MQ4 2024: $2.25MQ1 2025: $9.80MQ2 2025: $11.2MQ3 2025: $20.9MQ4 2025: $16.6MQ1 2026: $28.2MQ2 2026: $15.3M
Institutions holding ELTX and their total value by quarter
QuarterHoldersValue
Q2 202648$15.3M
Q1 202647$28.2M
Q4 202537$16.6M
Q3 202528$20.9M
Q2 202521$11.2M
Q1 202524$9.80M
Q4 202417$2.25M
Q3 202418$2.48M
Q2 202420$2.68M
Q1 202418$3.08M
Q4 202318$2.78M
Q3 202318$2.80M
Q2 202315$2.71M
Q1 202328$2.56M
Q4 202230$3.98M
Q3 202238$4.71M
Q2 202243$5.90M
Q1 202247$13.8M
Q4 202153$20.3M
Q3 202147$69.3M
Q2 202141$66.5M
Q1 202141$92.0M

Institutions, Q1 2026

Shares, value and share of portfolio for each institution holding Elicio Therapeutics, Inc.; share changes are against Q4 2025.

Institutions holding ELTX in Q1 2026
InstitutionSharesValue% of portfolioChange in sharesAction
Royal Bank of Canada23$00.00%−196−89.5%Reduced
Tower Research Capital LLC (TRC)1$110.00%+1New
Caitong International Asset Management Co., Ltd3$320.00%+3New
SBI Securities Co., Ltd.82$8770.00%00.0%Unchanged
Farther Finance Advisors, LLC721$7.69K0.00%+16+2.3%Added
Steward Partners Investment Advisory, LLC2,023$21.6K0.00%+469+30.2%Added
EFG International AG2,200$23.5K0.00%+2,200New
Vanguard Global Advisers, LLC4,416$47.2K0.00%+4,416New
BNP Paribas Arbitrage, SA6,344$67.8K0.00%+676+11.9%Added
Wiley Bros.-Aintree Capital, LLC10,000$106.9K0.00%00.0%Unchanged
Moody Lynn & Lieberson, LLC10,000$106.9K0.01%00.0%Unchanged
Mayflower Financial Advisors, LLC10,000$106.9K0.01%00.0%Unchanged
Summit Financial, LLC10,010$107.0K0.00%00.0%Unchanged
HB Wealth Management, LLC10,463$111.8K0.00%+10,463New
Omers Administration Corp10,700$114.4K0.00%−12,800−54.5%Reduced
Raymond James Financial Inc11,100$118.7K0.00%+11,100New
HighTower Advisors, LLC11,166$119.4K0.00%−20−0.2%Reduced
Cresset Asset Management, LLC11,425$122.1K0.00%+11,425New
Qube Research & Technologies Ltd12,482$133.4K0.00%−7,734−38.3%Reduced
Engineers Gate Manager LP13,160$140.7K0.00%+13,160New
XTX Topco Ltd13,785$147.4K0.00%+13,785New
Kingswood Wealth Advisors, LLC13,800$147.5K0.01%+13,800New
Meyer Handelman Co13,899$148.6K0.00%00.0%Unchanged
Bank of America Corp15,333$163.9K0.00%+14,176+1,225.2%Added
Citadel Advisors LLC15,978$170.8K0.00%+15,978New
Quadrature Capital Ltd16,912$180.8K0.00%−247−1.4%Reduced
Brevan Howard Capital Management LP17,401$186.0K0.00%+17,401New
Hudson Bay Capital Management LP20,208$216.0K0.00%+20,208New
HRT Financial LP21,611$231.0K0.00%+21,611New
CM Management, LLC25,000$267.3K0.22%00.0%Unchanged
Iridian Asset Management LLC30,051$321.2K0.13%+30,051New
Morgan Stanley32,404$346.4K0.00%+17,851+122.7%Added
UBS Group AG33,769$361.0K0.00%+1,753+5.5%Added
BlackRock, Inc.50,597$540.9K0.00%+5,418+12.0%Added
State Street Corp50,620$541.1K0.00%+4,320+9.3%Added
683 Capital Management, LLC56,442$603.4K0.06%00.0%Unchanged
Goldman Sachs Group Inc57,818$618.1K0.00%+57,818New
Northern Trust Corp59,734$638.6K0.00%+6,965+13.2%Added
Vanguard Fiduciary Trust Co69,189$739.6K0.00%+69,189New
Susquehanna International Group, LLP70,804$756.9K0.00%+6,752+10.5%Added
Marshall Wace, LLP74,512$796.5K0.00%−42,688−36.4%Reduced
Millennium Management LLC92,762$991.6K0.00%+92,762New
Renaissance Technologies LLC121,631$1.30M0.00%+93,520+332.7%Added
Geode Capital Management, LLC135,164$1.45M0.00%+2,646+2.0%Added
Balyasny Asset Management LLC244,814$2.62M0.01%+106,052+76.4%Added
Vanguard Capital Management LLC518,638$5.54M0.00%+518,638New
Knoll Capital Management, LLC630,915$6.74M3.74%00.0%Unchanged
Squarepoint Ops LLC0$00.00%−16,662−100.0%Sold out
Occudo Quantitative Strategies LP0$00.00%−15,827−100.0%Sold out
Jefferies Financial Group Inc.0$00.00%−11,942−100.0%Sold out
Point72 Asset Management, L.P.0$00.00%−11,652−100.0%Sold out
Group One Trading, L.P.0$00.00%−323−100.0%Sold out
Wells Fargo & Company0$00.00%−200−100.0%Sold out
Fortitude Family Office, LLC0$00.00%−93−100.0%Sold out
Vanguard Group Inc––––Not filed
CIBC Private Wealth Group, LLC––––Not filed